IGM Biosciences Inc IGMS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:35 PM EDT
10.19quote price arrow up+0.16 (+1.60%)
Volume
46,845
52 week range
3.81 - 17.70
Loading...
  • Open10.02
  • Day High10.19
  • Day Low9.83
  • Prev Close10.03
  • 52 Week High17.70
  • 52 Week High Date02/20/24
  • 52 Week Low3.81
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap600.732M
  • Shares Out58.95M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta0.26
  • YTD % Change20.58

KEY STATS

  • Open10.02
  • Day High10.19
  • Day Low9.83
  • Prev Close10.03
  • 52 Week High17.70
  • 52 Week High Date02/20/24
  • 52 Week Low3.81
  • 52 Week Low Date11/01/23
  • Market Cap600.732M
  • Shares Out58.95M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta0.26
  • YTD % Change20.58

RATIOS/PROFITABILITY

  • EPS (TTM)-4.81
  • P/E (TTM)-2.12
  • Fwd P/E (NTM)-3.20
  • EBITDA (TTM)-255.088M
  • ROE (TTM)-100.48%
  • Revenue (TTM)2.13M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-11,568.83%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IGM Biosciences Inc

 

Profile

MORE
IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only two binding sites. It is also focused on creating, developing, manufacturing, and commercializing IgM...
Fred Schwarzer J.D.
President, Chief Executive Officer, Director
Misbah Tahir CPA
Chief Financial Officer
Address
325 E Middlefield Rd
Mountain View, CA
94043-4003
United States

Top Peers

SYMBOLLASTCHG%CHG
PHAT
Phathom Pharmaceuticals Inc
10.48-0.36-3.32%
OLMA
Olema Pharmaceuticals Inc
10.98+0.08+0.73%
AVTE
Aerovate Therapeutics Inc
20.16-0.46-2.23%
LYEL
Lyell Immunopharma Inc
2.50-0.04-1.77%
CABA
Cabaletta Bio Inc
13.16+0.30+2.33%